🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a phase 1, randomized, double-blind, placebo-controlled, sequentia...
Status
Completed
Location
Clinical Pharmacology of Miami, Inc.
Start Date
2015-11-24
Trial ID
NCT03072407
Treatments Being Tested
This is an open label, multiple dose study, pharmacokinetic and pharmacodyn...
Status
Completed
Location
Peking University First Hospital
Start Date
2014-11-15
Trial ID
NCT03062774
Treatments Being Tested
GLP-1 analogues have been widely used because of their unique advantages (n...
Status
Completed
Location
Peking University First Hospital
Start Date
2014-02
Trial ID
NCT02084251
Treatments Being Tested
This study is a single-dose, parallel grouping, open-label phase I clinical...
Status
Unknown
Location
Jia Miao
Start Date
2022-05-01
Trial ID
NCT05328843
Treatments Being Tested
A randomized, double-blind, placebo-controlled study to evaluate the effica...
Status
Completed
Location
Central South University The Second Xiangya Hospital
Start Date
2020-04-27
Trial ID
NCT04504370
Treatments Being Tested
This is a randomized, opened, positive drug-controlled (Exenatide, Byetta),...
Status
Completed
Location
No.1 Hospital of Peking University
Start Date
2015-04-08
Trial ID
NCT03059719
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled study to evaluate th...
Status
Completed
Location
Beijing University People's Hospital
Start Date
2020-06-23
Trial ID
NCT04504396
Treatments Being Tested
The trial is conducted in a single-center, randomized, double-blind, placeb...
Status
Completed
Location
The Third XIANGYA Hospital of Central South University
Start Date
2024-05-27
Trial ID
NCT06350812
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
Peking University People's Hospital
Start Date
2018-06-05
Trial ID
NCT03520972
Treatments Being Tested